BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16363237)

  • 1. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
    de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
    Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
    Meyer M; Bergmann F; Brennan SO
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of hypofibrinogenemia and factor V Leiden mutation: is the balance shifted to thrombosis?
    Miljić P; Nedeljkov-Jančić R; Zuvela M; Subota V; Dorđević V
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):628-30. PubMed ID: 24637696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
    Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
    Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain.
    Brennan SO; Wyatt JM; May S; De Caigney S; George PM
    Thromb Haemost; 2001 Mar; 85(3):450-3. PubMed ID: 11307813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
    Castaman G; Giacomelli SH; Duga S; Rodeghiero F
    Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
    Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
    Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
    Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
    Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal fibrinogen Zlín (γThr21Ile) with missense mutation causing hypofibrinogenemia.
    Riedelová-Reicheltová Z; Riedel T; Májek P; Kotlin R; Geierová V; Suttnar J; Dyr JE
    Acta Haematol; 2014; 132(2):140-3. PubMed ID: 24556703
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia.
    Brennan SO; Maghzal G; Shneider BL; Gordon R; Magid MS; George PM
    Hepatology; 2002 Sep; 36(3):652-8. PubMed ID: 12198657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel mutations in the fibrinogen γ nodule.
    Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
    Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.
    Kumar R; Dawson J; Varga E; Canini JT; Monda KL; Dunn AL
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27832. PubMed ID: 31131962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.
    Brennan SO; Fellowes AP; Faed JM; George PM
    Blood; 2000 Mar; 95(5):1709-13. PubMed ID: 10688828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.